Drugs News and Research

RSS

Tiny 3D brain models could accelerate drug research for multiple sclerosis

Tiny 3-D models that mimic vital aspects of the human nervous system have been developed in a step that could accelerate drug research for neurological conditions such as multiple sclerosis (MS).

3 May 2021

NSAIDs could help mitigate the short-term impacts of air pollution on cognition

Exposure to air pollution, even over the course of just a few weeks, can impede mental performance, according to a new study led by researchers at Columbia University Mailman School of Public Health.

3 May 2021

Designing effective multidrug-resistant-TB treatments based on DNA sequencing

Globally, tuberculosis is the most common bacterial infectious disease leading to death. The pathogen causing tuberculosis, Mycobacterium tuberculosis, has a number of peculiarities. One is that it is growing very slowly.

3 May 2021

Scientists investigate the role played by genes and environment in multiple substance use

Many drug addicts take not only one substance but rather several. Scientists at the Max Planck Institute of Experimental Medicine in Göttingen have investigated the role that genes and the environment play in the development of such multiple substance consumption or polytoxicomania.

3 May 2021

Chemotherapy drugs delivered via nanoparticles could improve bowel cancer survival rates

Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment.

3 May 2021

FDA approves new drug for treatment of adults with chronic kidney disease

Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.

30 Apr 2021

Applications of nanoparticles in combating COVID-19

Researchers review the various properties and use of nanoparticles in targeting SARS-CoV-2 and how they could be used to develop new therapeutics and diagnostics for SARS-CoV-2.

30 Apr 2021

FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose

The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products.

30 Apr 2021

Despite all the talk, Covid vaccination does not infect people with shingles

Posts are showing up all over social media tying Covid-19 vaccinations to shingles and other painful skin disorders.

30 Apr 2021

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.

30 Apr 2021

Researchers develop novel algorithm for the diagnostics of dementia

Researchers from the University of Eastern Finland and the University of Oulu in collaboration with an international team have created a new diagnostic biomarker-based algorithm for the diagnostics of dementia.

30 Apr 2021

The Christie NHS Foundation Trust first to offer treatment in cancer patients’ homes

One of Europe’s largest cancer centres, The Christie NHS Foundation Trust, has become the first in the country to provide a treatment called Phesgo for breast cancer patients in their own homes. Phesgo is a combination of Herceptin

30 Apr 2021

Study shows how tau spreads to four distinct patterns leading to different Alzheimer's symptoms

Alzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can now show how tau spreads according to four distinct patterns that lead to different symptoms with different prognoses of the affected individuals.

30 Apr 2021

New study reveals mechanisms that result in lethal COVID-19

A new study is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, revealing mechanisms that result in lethal COVID-19, and may explain long-term complications and show how COVID-19 differs from other infectious diseases.

30 Apr 2021

Frontline clinician scientists recommend more proactive guidelines to deal with pandemics

A new editorial written by clinical academics working on the frontline of the Covid-19 pandemic has warned that national guidelines need to adapt in the face of pandemics.

30 Apr 2021

Blood pressure-lowering medication can prevent serious cardiovascular conditions

Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failure and heart attacks even in adults with normal blood pressure, according to new research published in The Lancet.

30 Apr 2021

Novel compound in avocados may offer a route to better leukemia treatment

A compound in avocados may ultimately offer a route to better leukemia treatment, says a new University of Guelph study.

29 Apr 2021

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline.

29 Apr 2021

New genetically encoded sensor helps detect drugs of abuse

A genetically encoded sensor to detect hallucinogenic compounds has been developed by researchers at the University of California, Davis. Named psychLight, the sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse. The work is published April 28 in the journal Cell.

29 Apr 2021

Repairing faulty drains could be key to unlocking the potential of Alzheimer's therapies

Experimental Alzheimer's drugs have shown little success in slowing declines in memory and thinking, leaving scientists searching for explanations.

29 Apr 2021

Drugs News and Research

Tiny 3D brain models could accelerate drug research for multiple sclerosis

NSAIDs could help mitigate the short-term impacts of air pollution on cognition

Designing effective multidrug-resistant-TB treatments based on DNA sequencing

Scientists investigate the role played by genes and environment in multiple substance use

Chemotherapy drugs delivered via nanoparticles could improve bowel cancer survival rates

FDA approves new drug for treatment of adults with chronic kidney disease

Applications of nanoparticles in combating COVID-19

FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose

Despite all the talk, Covid vaccination does not infect people with shingles

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

Researchers develop novel algorithm for the diagnostics of dementia

The Christie NHS Foundation Trust first to offer treatment in cancer patients’ homes

Study shows how tau spreads to four distinct patterns leading to different Alzheimer's symptoms

New study reveals mechanisms that result in lethal COVID-19

Frontline clinician scientists recommend more proactive guidelines to deal with pandemics

Blood pressure-lowering medication can prevent serious cardiovascular conditions

Novel compound in avocados may offer a route to better leukemia treatment

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer

New genetically encoded sensor helps detect drugs of abuse

Repairing faulty drains could be key to unlocking the potential of Alzheimer's therapies

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News